Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Caresyntax
AddedFeb 13, 2024
UpdatedJun 18, 2026
Caresyntax

Caresyntax

Series C

Caresyntax, Inc.: A global provider of surgical analytics, risk management, and workflow automation.

HQ
Boston, MA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Caresyntax, Inc. is a global provider of surgical analytics, risk management, and workflow automation. The company empowers surgeons and healthcare providers to improve patient outcomes, enhance operational efficiency, and increase profitability through data-driven surgery using AI, automation, and OR analytics. Caresyntax's platform helps hospitals and ambulatory surgical centers identify and manage risk, automate workflows, enhance knowledge sharing, and reduce surgical variability.

Caresyntax has made significant strides in the healthcare industry by leveraging advanced technology to optimize surgical procedures. Their solutions have been adopted by numerous healthcare facilities worldwide, contributing to improved clinical, financial, and operational outcomes. The company's innovative approach has garnered attention from notable investors and industry leaders, solidifying its reputation as a key player in the realm of surgical technology.

Caresyntax - Similar Companies

CareSkore logo

CareSkore

careskore.com

Syntax Health logo

Syntax Health

meetsyntax.com

Click4Care logo

Click4Care

SurgeonCheck logo

SurgeonCheck

surgeoncheck.com

CaseCTRL logo

CaseCTRL

casectrl.com

Copient Health logo

Copient Health

copienthealth.com

kelaHealth logo

kelaHealth

kelahealth.com

surgical.ai logo

surgical.ai

surgical.ai

Autonomous Healthcare logo

Autonomous Healthcare

Care Analytics logo

Care Analytics

careanalytics.net

care.ai logo

care.ai

care.ai

DocSpera logo

DocSpera

docspera.com

CareAlign logo

CareAlign

carealign.ai

ORtelligence logo

ORtelligence

ortelligence.com

CareWork logo

CareWork

mycarework.com

Caresyntax - Quick Facts

Who are Caresyntax's competitors?

Companies similar to Caresyntax include CareSkore, Syntax Health, Click4Care and SurgeonCheck.

When was Caresyntax founded?

Caresyntax was founded in 2013.

Where is Caresyntax's headquarters located?

Caresyntax's headquarters is located in Boston, MA, US.

When was Caresyntax's last funding round?

Caresyntax's most recent funding round was for $130M (USD) in September 2021.

How much has Caresyntax raised to-date?

As of Sep 16, 2021, Caresyntax has raised a total of $207.5M (USD).

How many employees does Caresyntax have?

Caresyntax has 193 employees as of Feb 5, 2024.

Caresyntax - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • AI
  • Analytics
  • Automation
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Risk Management
  • Surgical Analytics
Tags
  • Consulting
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 7 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software